Inflammopharmacology 14 (2006) 178 0925-4692/06/020178-1 DOI 10.1007/s10787-006-0008-z © Birkhäuser Verlag, Basel, 2006
Inflammopharmacology
Editorial Proceedings of the Combined Meeting of the 12th International Conference on Ulcer Research (ICUR) and the Satellite Meeting of the Gastrointestinal (GI) Section of IUPHAR Osaka (Japan) July 7–9th, 2006 Some of the papers that follow in this issue of INFLAMMOPHARMACOLOGY as indicated [*] on the contents page are a selection of those presentations at the above meeting in Osaka, the papers from which were peer-reviewed. Full details concerning the programme for this conference and abstracts will be found in a recent issue of Digestion, and details can be found at www.b-comm.gr.jp/ICUR. The conference was attended by over 400 delegates from all points of the globe and was an outstanding success. Special thanks are due to the outstanding efforts of the Local Organizing Committee comprising Professor Tetsuo Arakawa (Chairman), Professor Koji Takeuchi (Vice-Chairman), Professor Tsutomu Chiba, Professor Kazuhide Higuchi (Secretary General), Professor Sunao Kawano, Professor Hajime Kuwayama, Professor Shin-ichi Takahashi, Professor Takashi Joh and Professor Toshikazu Yoshikawa. The excellent support in organization of the venue and secretarial support was provided by Mr. Yosuke Komori (Secretariat of the 12th ICUR, c.f. Keiso Shobo Publishing Co. Ltd., Tokyo, Japan) and his able team of willing helpers. This conference would not have been possible without the valuable financial support of the following organizations Supported by: Osaka Prefectural Government Osaka City The Uehara Memorial Foundation Alumni Association of the 3rd Department of Internal Medicine, Osaka City University Graduate School of Medicine In corporation with: Japan National Tourist Organization Major Sponsors: Otsuka Pharmaceutical Co., Ltd. Eisai Co., Ltd.
Contributors: ABBOTT JAPAN CO., LTD. AMCO Incorporated Astellas Pharma Inc. AstraZeneca K.K. Banyu Pharmaceutical Co., Ltd. Boston Scientific Corporation Chugai Pharmaceutical Co., Ltd. Daiichi Pharmaceutical Co., Ltd. Dainippon Sumitomo Pharma Co., Ltd. FUJINON TOSHIBA ES SYSTEM CO., LTD. Given Imaging Ltd. GlaxoSmithKline K.K. JIMRO Co., Ltd. Minophagen Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Ono Pharmaceutical Co., Ltd. PENTAX Corporation Sankyo Co., Ltd. Schering-Plough K.K. Shionogi & Co., Ltd. Taiho Pharmaceutical Co., Ltd. Taisho Toyama Pharmaceutical Co., Ltd. Takeda Pharmaceutical Co., Ltd. TANABE SEIYAKU CO., LTD. Toray Medical Co., Ltd. TSUMURA & CO. UCB Japan Co., Ltd. Yakult Honsha Co., Ltd. ZERIA Pharmaceutical Co., Ltd. The Editors of these proceedings, the Local Organizing Committee and the Standing Committee of ICUR are totally responsible for the contents of this publication. T. Arakawa, Gy. Mozsik, K.D. Rainsford and K.TakeuchiProceedings Editors.